Login to Your Account

Evotec Shares Rise on Kidney Disease Pact with Astrazeneca

By Cormac Sheridan
Staff Writer

Wednesday, October 23, 2013

Shares in Evotec AG rose 10 percent Monday on news of a research partnership with Astrazeneca plc on the discovery and development of disease-modifying drugs for chronic kidney disease.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription